Standard Biotools reported $-26.76M in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
Agilent USD 362M 23M Jun/2026
Becton, Dickinson and Co. USD 696M 319M Sep/2026
Bio-Rad Laboratories USD 371.4M 898.5M Jun/2026
Bruker USD -122.8M 59.9M Sep/2026
Danaher USD 1.24B 365M Sep/2026
Illumina USD 220M 13M Sep/2026
Myriad Genetics USD -7.9M 19.5M Dec/2025
Nikon Corporation JPY 9.37B 8.08B Sep/2026
Pacific Biosciences Of California USD -40.37M 2.37M Dec/2025
Revvity USD 62.3M 10.48M Sep/2026
Roche Holding CHF 6.87B 1.4B Jun/2026
Sony JPY 449.6B 107.44B Sep/2026
Standard Biotools USD -26.76M 153.83M Jun/2026
Thermo Fisher Scientific USD 1.72B 15M Sep/2026
Waters USD -136M 64M Jun/2026